TVTX icon

Travere Therapeutics

168 hedge funds and large institutions have $1.7B invested in Travere Therapeutics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 60 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
Holders Change %
0%
% of All Funds
2.66%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
22
Increased
62
Reduced
60
Closed
21
Calls
$4.43M
Puts
$2.43M
Net Calls
+$2M
Net Calls Change
+$1.99M
Name Holding Trade Value Shares
Change
Shares
Change %
CC
176
Corton Capital
Ontario, Canada
-$414K -13,349 Closed
Jane Street
177
Jane Street
New York
-$314K -10,104 Closed
CA
178
Calton & Associates
Florida
-$298K -9,608 Closed
GCM
179
Graham Capital Management
Connecticut
-$241K -7,791 Closed
CCIA
180
Campbell & Co Investment Adviser
Maryland
-$227K -7,300 Closed
Principal Financial Group
181
Principal Financial Group
Iowa
-$226K -7,267 Closed
CAM
182
Cresset Asset Management
Illinois
-$222K -7,139 Closed
Marshall Wace
183
Marshall Wace
United Kingdom
-$213K -6,866 Closed
Bank of Montreal
184
Bank of Montreal
Ontario, Canada
-$206K -6,798 Closed
Walleye Trading
185
Walleye Trading
New York
-$97K -3,114 Closed
QT
186
Quantbot Technologies
New York
-$10K -341 Closed
DFCM
187
Dark Forest Capital Management
Puerto Rico
-$4K -120 Closed
FHA
188
First Horizon Advisors
Tennessee
-$1K -46 Closed